These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36670543)

  • 1. Expression of epidermal growth factor receptor and human epidermal growth factor receptor 2 in urothelial bladder carcinoma in an Egyptian cohort: Clinical implication and prognostic significance.
    Sami MM; Sherief MH; El-Abaseri TB; El-Sakka AI; El-Serafi AT
    Urologia; 2023 May; 90(2):248-260. PubMed ID: 36670543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.
    Kolla SB; Seth A; Singh MK; Gupta NP; Hemal AK; Dogra PN; Kumar R
    Int Urol Nephrol; 2008; 40(2):321-7. PubMed ID: 17899426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
    Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
    BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 Affects the Biological Behaviours of Bladder Cancer Cells and is Closely Associated with the Progression and Prognosis of Bladder Cancer.
    Li Q; Su X; Qing L; Xu W; Yang Y; You C; Wang J; Dong Z
    Arch Esp Urol; 2024 Jan; 77(1):79-91. PubMed ID: 38374017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review.
    Sanguedolce F; Russo D; Mancini V; Selvaggio O; Calò B; Carrieri G; Cormio L
    Urol Int; 2019; 102(3):249-261. PubMed ID: 30463072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of HER2 expression in urothelial carcinoma.
    Rosli N; Mahasin M; Mohd Saleh MF; Abd Shukor N
    Malays J Pathol; 2022 Aug; 44(2):245-252. PubMed ID: 36043587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
    Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
    Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder.
    Olsson H; Fyhr IM; Hultman P; Jahnson S
    Scand J Urol Nephrol; 2012 Apr; 46(2):102-7. PubMed ID: 22150625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma.
    Hashimoto M; Fujita K; Tomiyama E; Fujimoto S; Adomi S; Banno E; Minami T; Takao T; Nozawa M; Fushimi H; Yoshimura K; Nonomura N; Uemura H
    Anticancer Res; 2023 Jan; 43(1):167-174. PubMed ID: 36585180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
    Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival.
    Helal DS; Darwish SA; Awad RA; Ali DA; El-Guindy DM
    Diagn Pathol; 2023 Feb; 18(1):11. PubMed ID: 36737799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.
    Lim SD; Cho YM; Choi GS; Park HK; Paick SH; Kim WY; Kim SN; Yoon G
    J Korean Med Sci; 2015 Aug; 30(8):1068-77. PubMed ID: 26240484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of replication protein A3 is associated with unfavorable outcome in bladder urothelial carcinoma.
    Sun D; Zhang K; Fu Q; Zhang H; Liu S; Wang H; Xu Z; Wang J
    J Cancer Res Ther; 2021 Jul; 17(3):771-776. PubMed ID: 34269312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor expression as a predictor of chemotherapeutic resistance in muscle-invasive bladder cancer.
    Mansour AM; Abdelrahim M; Laymon M; Elsherbeeny M; Sultan M; Shokeir A; Mosbah A; Abol-Enein H; Awadalla A; Cho E; Sairam V; Park TD; Shahid M; Kim J
    BMC Urol; 2018 Nov; 18(1):100. PubMed ID: 30413194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer.
    Colquhoun AJ; Sundar S; Rajjayabun PH; Griffiths TR; Symonds RP; Mellon JK
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):702-9. PubMed ID: 17100158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
    Gandour-Edwards R; Lara PN; Folkins AK; LaSalle JM; Beckett L; Li Y; Meyers FJ; DeVere-White R
    Cancer; 2002 Sep; 95(5):1009-15. PubMed ID: 12209684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
    Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.